Analytical Data
-
基因名
CKLF
- Application
-
别名
CKLF；CKLF1；Chemokine-like factor
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UBR5
-
表达区间
1-152aa
-
氨基酸序列
MDNVQPKIKHRPFCFSVKGHVKMLRLALTVTSMTFFIIAQAPEPYIVITGFEVTVILFFILLYVLRLDRLMKWLFWPLLDIINSLVTTVFMLIVSVLALIPETTTLTVGGGVFALVTAVCCLADGALIYRKLLFNPSGPYQKKPVHEKKEVL
-
分子量
17.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of CKLF (Chemokine-Like Factor) recombinant protein has emerged as a significant area of research due to its pivotal role in immune response and inflammation. Initially discovered as a chemokine-like molecule, CKLF is implicated in various biological processes, particularly in the migration and activation of immune cells. Its unique structure and functional properties make it an attractive target for therapeutic development, especially in the context of autoimmune diseases, cancer, and infectious diseases. Understanding the molecular mechanisms by which CKLF regulates immune activities can provide insights into potential interventions for controlling undesirable inflammatory responses. Moreover, the advancement of recombinant protein technology has enabled researchers to produce CKLF in sufficient quantities for detailed functional studies. These studies aim to clarify its signaling pathways and interaction with specific receptors, which may pave the way for novel immunomodulatory treatments. Given the increasing prevalence of diseases associated with dysregulated immune responses, the exploration of CKLF as a therapeutic agent highlights its potential utility in modern medicine, encouraging further investigations and applications in clinical settings.
